Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -25.9%
CGEM
Cullinan Therapeutics, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 12.7 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -22.1%
- 5yr Share-Count CAGR 6.3%
Growth Quality
Weight: 15%
F
0
- Revenue-Growth Years (5) 0/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -232.4%
- 5yr FCF/NI Conversion -1.15x
Balance Sheet
Weight: 20%
C
55
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 17.64
Stability
Weight: 15%
F
11
- Piotroski F-Score 1
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 1 gurus held; 1 trimmed; 1 full exit.
- Holders
- 1
- Avg Δ position
- -91.7%
- New buys
- 0
- Full exits
- 1